المؤلفون: Stroes, Erik, Guyton, John R., Lepor, N., Civeira, F., Gaudet, D., Watts, Gerald F., Baccara-Dinet, Marie T., Lecorps, Guillaume, Manvelian, Garen, Farnier, Michel, Kostner, K., Lehman, S., Descamps, O., Gheyle, L., Mathieu, C., Bergeron, J., Elliott, T., Girard, G., Gupta, A., Hoag, G., Hove, J., Jeppesen, J., Kjærulf, J. H., Klarlund, K., Thomsen, K. K., Basart, D. C.G., Kooy, A., Liem, A., Stroes, J. E.S.G., Swart, H., Troquay, R., Van Het Hof-Wiersma, J., Viergever, P., Visseren, F., Doughty, R. N., Scott, R., Calvo, C., Díaz-Díaz, J. L., Fuentes, F., Gil-Extremera, B., Jericó, C., Matas Pericas, L., Mediavilla Garcia, J. D., Bolster, D. E., Guyton, J., Koren, M., El Shahawy, M.

المصدر: Stroes , E , Guyton , J R , Lepor , N , Civeira , F , Gaudet , D , Watts , G F , Baccara-Dinet , M T , Lecorps , G , Manvelian , G , Farnier , M , Kostner , K , Lehman , S , Descamps , O , Gheyle , L , Mathieu , C , Bergeron , J , Elliott , T , Gaudet , D , Girard , G , Gupta , A , Hoag , G , Hove , J , Jeppesen , J , Kjærulf , J H ....

مصطلحات موضوعية: Alirocumab, Cardiovascular risk, Low-density lipoprotein cholesterol, Placebo-controlled, Proprotein convertase subtilisin/kexin type 9

الإتاحة: https://doi.org/10.1161/JAHA.116.003421Test
https://curis.ku.dk/portal/da/publications/efficacy-and-safety-of-alirocumab-150-mg-every-4-weeks-in-patients-with-hypercholesterolemia-not-on-statin-therapyTest(b4bccfce-06ae-4e45-a315-e90d6b46df06).html

المؤلفون: Stroes, Erik, Guyton, John R., Lepor, Norman, Civeira, Fernando, Gaudet, Daniel, Watts, Gerald F., Baccara‐Dinet, Marie T., Lecorps, Guillaume, Manvelian, Garen, Farnier, Michel, Kostner, K., Lehman, S., Descamps, O., Gheyle, L., Mathieu, C., Bergeron, J., Elliott, T., Girard, G., Gupta, A., Hoag, G., Hove, J., Jeppesen, J., Kjærulf, J.H., Klarlund, K., Thomsen, K.K., Basart, D.C.G., Kooy, A., Liem, A., Swart, H., Troquay, R., Van Het Hof‐Wiersma, J, Viergever, P., Visseren, F., Doughty, R.N., Scott, R., Calvo, C., Díaz‐Díaz, J.L., Fuentes, F., Gil‐Extremera, B., Jericó, C., Matas Pericas, L., Mediavilla Garcia, J.D., Bolster, D.E., Koren, M., El Shahawy, M., Vardi, G., Weinstein, D., Zuzarte, K., Ginsberg, Henry, Robinson, Jennifer G.

المصدر: Journal of the American Heart Association ; volume 5, issue 9 ; ISSN 2047-9980

الإتاحة: https://doi.org/10.1161/jaha.116.003421Test

المؤلفون: Stroes E, Guyton JR, Lepor N, Civeira F, Gaudet D, Watts GF, Baccara-Dinet MT, Lecorps G, Manvelian G, Farnier M, ODYSSEY CHOICE II Investigators. K Kostner, S Lehman, O Descamps, L Gheyle, C Mathieu, J Bergeron, T Elliott, G Girard, A Gupta, G Hoag, J Hove, J Jeppesen, J H Kjærulf, K Klarlund, K K Thomsen, D C G Basart, A Kooy, A Liem, H Swart, R Troquay, J Van Het Hof-Wiersma, P Viergever, F Visseren, R N Doughty, R Scott, C Calvo, J L Díaz-Díaz, F Fuentes, B Gil-Extremera, C Jericó, L Matas Pericas, J D Mediavilla Garcia, D E Bolster, M Koren, M El Shahawy, G Vardi, D Weinstein, K Zuzarte, Henry Ginsberg, Jennifer G Robinson, Daniel J Rader, Christopher P Cannon, Helen Colhoun, John J P Kastelein, Yong Huo, Anders Olsson, David Waters, Dominique Larrey, Robert S Rosenson, Peter A Patriarca, Geert Molenberghs, Pierluigi Tricoci, Kenneth W Mahaffey, Renato D Lopes, Bimal R Shah, Rajendra H Mehta, Matthew T Roe, Zubin Eapen, Luciana Armaganijan, Adriana Bertolami, Sergio Leonardi, Bradley J Kolls, J Dedrick Jordan, Grégory Ducrocq, Etienne Puymirat, Robin Mathews

المساهمون: E, Stroe, Jr, Guyton, N, Lepor, F, Civeira, D, Gaudet, Gf, Watt, Mt, Baccara-Dinet, G, Lecorp, G, Manvelian, M, Farnier, K Kostner, ODYSSEY CHOICE II Investigators., Lehman, S, Descamps, O, Gheyle, L, Mathieu, C, Bergeron, J, Elliott, T, Girard, G, Gupta, A, Hoag, G, Hove, J, Jeppesen, J, H Kjærulf, J, Klarlund, K, K Thomsen, K, G Basart, D C, Kooy, A, Liem, A, Swart, H, Troquay, R, Van Het Hof-Wiersma, J, Viergever, P, Visseren, F, N Doughty, R, Scott, R, Calvo, C, L Díaz-Díaz, J, Fuentes, F, Gil-Extremera, B, Jericó, C, Matas Pericas, L, D Mediavilla Garcia, J, E Bolster, D, Koren, M, El Shahawy, M, Vardi, G, Weinstein, D, Zuzarte, K, Ginsberg, Henry, G Robinson, Jennifer, J Rader, Daniel, P Cannon, Christopher, Colhoun, Helen, P Kastelein, John J, Huo, Yong, Olsson, Ander, Waters, David, Larrey, Dominique, S Rosenson, Robert, A Patriarca, Peter, Molenberghs, Geert, Tricoci, Pierluigi, W Mahaffey, Kenneth, D Lopes, Renato, R Shah, Bimal, H Mehta, Rajendra, T Roe, Matthew, Eapen, Zubin, Armaganijan, Luciana, Bertolami, Adriana, Leonardi, Sergio, J Kolls, Bradley, Dedrick Jordan, J, Ducrocq, Grégory, Puymirat, Etienne, Mathews, Robin

مصطلحات موضوعية: Alirocumab, Cardiovascular risk, Low-density lipoprotein cholesterol, Placebo-controlled, Proprotein convertase subtilisin/kexin type 9, Aged, Antibodies, Monoclonal, Humanized, Anticholesteremic Agent, Cholesterol, LDL, Combined Modality Therapy, Double-Blind Method, Drug Therapy, Combination, Ezetimibe, Female, Fenofibrate, Human, Hypercholesterolemia, Hypolipidemic Agent, Injection Site Reaction, Male, Middle Aged, Proprotein Convertase 9, Treatment Outcome, Diet Therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27625344; info:eu-repo/semantics/altIdentifier/wos/WOS:000386716900015; volume:5; issue:9; journal:JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE; http://hdl.handle.net/11571/1341374Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85021220424

الإتاحة: https://doi.org/10.1161/JAHA.116.003421Test
http://hdl.handle.net/11571/1341374Test